Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $32.4000 (0.62%) ($32.3000 - $33.5000) on Mon. Oct. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.84% (three month average) | RSI | 56 | Latest Price | $32.4000(0.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.92% in a week (0% probabilities). IPO(-6%) VIXM(-5%) TLT(-5%) SLV(-5%) GLD(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.92% (StdDev 3.84%) | Hourly BBV | 0 () | Intraday Trend | -3% | | | |
|
Resistance Level | $33.36 | 5 Day Moving Average | $33.36(-2.88%) | 10 Day Moving Average | $33.51(-3.31%) | 20 Day Moving Average | $33.36(-2.88%) | To recent high | -20.8% | To recent low | 2.5% | Market Cap | $638m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |